Education
About Us
Working with TipRanks
Follow Us
NeuroPace (NPCE)
NASDAQ:NPCE
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.24Last Year’s EPS
-0.32Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 04, 2025
|% Change Since: -2.43%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Positive
NeuroPace demonstrated strong revenue growth and operational success in 2024, with significant advancements in clinical trials and product development. Despite a net loss and increased operating expenses, the company's strategic initiatives, including Project CARE and successful public offering, position it well for future growth. The overall sentiment is positive, given the successful financial and operational achievements overshadowing the financial challenges.Company Guidance
During the NeuroPace Fourth Quarter 2024 Earnings Call, the company provided guidance for 2025, projecting total revenue to be in the range of $92 million to $96 million, which represents a growth of approximately 15% to 20% over 2024. This growth is expected to be driven primarily by increased sales of the RNS system and contributions from Dixie Medical products. The company also anticipated maintaining gross margins between 73% and 75% for 2025, despite potential fluctuations due to the proportion of Dixie Medical revenue. Operating expenses for 2025 are expected to range between $92 million and $95 million, including approximately $11 million in stock-based compensation. NeuroPace's strategic focus on expanding adoption and utilization within level four comprehensive epilepsy centers, the continued rollout of Project CARE, and new indications for the RNS system are key drivers for their projected growth.Significant Revenue Growth
NeuroPace's total revenue grew by 22% in 2024 to $79.9 million, compared to $65.4 million in 2023. This growth was primarily driven by increased sales of the RNS system and Dixie Medical SEEG products.
Record Quarterly Revenue
NeuroPace reported record quarterly revenue in Q4 2024, with revenue of $21.5 million, representing a growth of 19% compared to $18 million in Q4 2023.
Gross Margin Stability
Gross margins for Q4 2024 were 75.4%, showing improvement from 75.2% in Q4 2023, demonstrating effective management of gross and operating margins.
Successful Public Offering
NeuroPace completed a public offering with net proceeds of approximately $69.8 million, which strengthened the balance sheet and supported long-term plans.
Project CARE Progress
The Project CARE program showed positive early trends, contributing to revenue growth in the second half of 2024 with increased implants and referrals.
Advancement in Clinical Trials
Positive three-year safety and effectiveness data from the ongoing post-approval study of the RNS system were announced, indicating unmatched seizure control.
Product Development Initiatives
NeuroPace is developing AI-enabled software tools and a next-generation platform to enhance efficiency and efficacy, including an AI-powered seizure classifier.
---
NPCE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NPCE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 04, 2025 | $11.92 | $11.63 | -2.43% |
| Nov 12, 2024 | $7.14 | $9.15 | +28.15% |
| Aug 13, 2024 | $7.28 | $6.77 | -7.01% |
| May 08, 2024 | $12.60 | $7.97 | -36.75% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does NeuroPace (NPCE) report earnings?
NeuroPace (NPCE) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is NeuroPace (NPCE) earnings time?
NeuroPace (NPCE) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NPCE EPS forecast?
NPCE EPS forecast for the fiscal quarter 2025 (Q1) is -0.24.
---